% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • break_thru_99 break_thru_99 May 6, 2013 11:47 AM Flag

    Got to love all of the paid pumpers on here...

    Take the lipstick off this pig. It's fair market value relative to Vivus is $6/share (or less). That's NOT even considering that Vivus is the company that has not one (unlike Arena) but TWO drugs currently on the market, one of which has been approved in Europe.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • too bad it isn't a game of how many pegs you have on the board. #$%$ pill is so good they cant keep it on shelves. and diet pill is so good doctors refuse to write generic scrips for it. Good luck, hope you make millions. Either way it wont affect me any... why are you here? Oh right. troll. ignore. I'm on a roll today.

    • Only one VVUS drug on the market, and only in the US, and ARNA's drug will outsell it at least 3-1 once rolling! That will support its valuation easily!

      The other VVUS drug is on a shelf collecting dust even with the EU recommendation and cockroaches are running thru the paperwork laying eggs!

      I want to see VVUS next quarters numbers---underacheive again is coming!



      Sentiment: Hold

2.34+0.19(+8.84%)1:29 PMEST